A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients
暂无分享,去创建一个
S. Bicciato | M. Benelli | A. Di Leo | L. Biganzoli | A. Grilli | L. Malorni | I. Migliaccio | A. McCartney | C. Biagioni | E. Risi | C. Guarducci | M. Bonechi | S. Vitale